In early 1994, Dow Corning Corporation debate whether to participate in the proposed $ 4.2 billion settlement of product liability. In particular, the firm must decide whether to contribute $ 2 billion to complete the costume class suit women suffering from connective tissue diseases, autoimmune diseases and other medical conditions, allegedly as a result of faulty silicone breast implants. Despite the denial of any impropriety, Dow Corning is accused of deliberately concealing information about the health risks associated with its implants for several decades. "Hide
by Willis Emmons, Greg Keller, Monica Brand Source: Harvard Business School 20 pages. Publication Date: November 14, 1994. Prod. #: 795047-PDF-ENG
Related Case Solutions & Analyses:
Investment Portfolio
Weight Solutions Clinic: Bariatric Surgery Center
Video-Cats: Wireframing and Prototyping
Brink’s Company: Activists Push For A Spin-Off
Dragonfly Corporation
China’s Renminbi: “Our Currency, Your Problem”?
Levi Strauss & Co. (C)
Silkor Laser Medical Center
A-CAT Corp.
Ajax Petroleum
